Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
13,307
-9,794
-42% -$1.28M 0.01% 829
2025
Q4
$3.15M Sell
23,101
-5,601
-20% -$806K 0.01% 709
2025
Q3
$4.23M Sell
28,702
-167,606
-85% -$23.2M 0.02% 599
2025
Q2
$25.4M Buy
196,308
+185,539
+1,723% +$22.5M 0.13% 229
2025
Q1
$1.29M Sell
10,769
-3,821
-26% -$474K 0.01% 732
2024
Q4
$1.69M Sell
14,590
-3,767
-21% -$476K 0.01% 682
2024
Q3
$2.48M Buy
+18,357
New +$2.46M 0.02% 454
2024
Q2
Sell
-133,901
Closed -$17.3M 693
2024
Q1
$17.3M Sell
133,901
-274,247
-67% -$33.1M 0.16% 193
2023
Q4
$46.7M Sell
408,148
-213,333
-34% -$21.3M 0.51% 57
2023
Q3
$56.6M Buy
621,481
+418,441
+206% +$43.2M 0.66% 34
2023
Q2
$22.9M Buy
203,040
+172,259
+560% +$18.2M 0.27% 108
2023
Q1
$3.22M Buy
+30,781
New +$3.21M 0.04% 353

Other funds holding XYL

Woodline Partners's XYL Position: Q1 2026 in Review

Woodline Partners reduced its Xylem (XYL) stake by 42% in Q1 2026, selling an estimated $1.28M and leaving 13,307 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #829.

Woodline Partners first reported a position in XYL in Q1 2023 and has held it in 12 quarters since. The position peaked at $56.6M in Q3 2023. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Woodline Partners held 13,307 shares of Xylem worth $1.59M as of Q1 2026.
  • Woodline Partners sold 9,794 Xylem shares in Q1 2026, an estimated $1.28M.
  • Xylem made up 0.01% of Woodline Partners's portfolio in Q1 2026, its #829 holding.
  • Woodline Partners first reported a position in Xylem in Q1 2023 and has held it in 12 quarters since.
  • Woodline Partners's Xylem position peaked at $56.6M in Q3 2023.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.